from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0259c/-

LFCtreatmentdescriptionclass of inhibitor

0.400

Amikacinug/mL Amikacintranslation

0.456

Cap5-10ug/mL Capreomycintranslation

1.004

Rox10-50 ug/mL Roxithromycintranslation

0.161

SM2-5 ug/mL Streptomycintranslation

0.146

Tet5-10 ug/mL Tetracyclinetranslation

-0.477

Rif0.2-5ug/mL Rifampicintranscription

-0.159

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.183

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.657

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.239

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.110

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.137

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.695

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.820

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.636

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.415

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.693

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.416

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.250

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.101

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.625

KCN5-20 ug/mL Potassium cyaniderespiration

-0.543

NaN30.2-2 mM Sodium aziderespiration

0.401

Nigericin50 uM Nigericinrespiration

-0.036

TRC10-150 ug/mL Triclosanrespiration

-0.637

TRZ10-25 ug/mL Thioridazinerespiration

1.902

Valinomycin0.5-10 uM Valinomycinrespiration

-2.091

ZnSO42 mM ZnSO4respiration

-0.785

menadione6-10 ug/mL Menadionerespiration

0.056

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.174

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.690

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.181

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.283

NRP_1Non-replicating persistence stage 1dosRassociated

-0.243

Amp0.2mg/mL AmpicillincellWall

-0.307

Cephalexin20-100 ug/mL CephalexincellWall

-0.096

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.729

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.321

EMB10-20 ug/mL EthambutolcellWall

-0.330

Eta12-40 ug/mL EthionamidecellWall

-0.377

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.411

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.025

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.778

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.367

BZA0.12 mg/mL BenzamidearomaticAmides

-0.420

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.054

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.551

H2O24 mM hydrogen peroxideDNAdamaging

0.402

Levo10 ug/mL LevofloxacinDNAdamaging

-1.060

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.141

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.030

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.233

UVUV-irradiationDNAdamaging

-0.256

ARP41-4 ug/mL Antitubercular compound ARP4?

0.531

Antimycin12.5-50 ug/mL Antimycin A?

-0.270

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.301

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.355

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.484

PA8240.2-2 ug/mL PA-824?

1.037

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.001

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.000

Verapamil50 uM Verapamil?

0.686

mercaptoethanol2 mM 2-Mercaptoethanol?

0.144

methoxatin10-20 ug/mL Methoxatin?